"HIV Infections/drug therapy"[MAJR] - Search Results

Year	Number of Results
1982	1
1983	1
1984	11
1985	18
1986	48
1987	84
1988	151
1989	286
1990	403
1991	298
1992	416
1993	492
1994	468
1995	795
1996	994
1997	1118
1998	1524
1999	1549
2000	1509
2001	1605
2002	1626
2003	1703
2004	1779
2005	1781
2006	1873
2007	1929
2008	2021
2009	2014
2010	2031
2011	2052
2012	2115
2013	2158
2014	2363
2015	2257
2016	2178
2017	2065
2018	2034
2019	2107
2020	2821
2021	3542
2022	3938
2023	3456
2024	2920
2025	1605

1

Toward a cure - Advancing HIV/AIDs treatment modalities beyond antiretroviral therapy: A Review.

Alum EU, Uti DE, Ugwu OP, Alum BN. Alum EU, et al. Medicine (Baltimore). 2024 Jul 5;103(27):e38768. doi: 10.1097/MD.0000000000038768. Medicine (Baltimore). 2024. PMID: 38968496 Free PMC article. Review.

2

Innovationen in Therapie und Prophylaxe der HIV-Infektion.

Bogner JR. Bogner JR. MMW Fortschr Med. 2022 Jun;164(Suppl 2):5. doi: 10.1007/s15006-022-0951-7. MMW Fortschr Med. 2022. PMID: 35731473 Free PMC article. German. No abstract available.

3

Emergent HIV drug resistance in non-inferiority trials.

Ripamonti D, Zazzi M. Ripamonti D, et al. Lancet HIV. 2023 Oct;10(10):e632-e634. doi: 10.1016/S2352-3018(23)00203-5. Epub 2023 Sep 12. Lancet HIV. 2023. PMID: 37714175 No abstract available.

4

Monoclonal CCR5 Antibody: A Promising Therapy for HIV.

Zhao L, Lai Y. Zhao L, et al. Curr HIV Res. 2023;21(2):91-98. doi: 10.2174/1570162X21666230316110830. Curr HIV Res. 2023. PMID: 36927434 Review.

5

Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy.

Dorward J, Lessells R, Govender K, Moodley P, Samsunder N, Sookrajh Y, Turner P, Butler CC, Hayward G, Gandhi M, Drain PK, Garrett N. Dorward J, et al. J Int AIDS Soc. 2023 Sep;26(9):e26172. doi: 10.1002/jia2.26172. J Int AIDS Soc. 2023. PMID: 37735860 Free PMC article.

6

Drug treatment of HIV-related opportunistic infections.

Klepser ME, Klepser TB. Klepser ME, et al. Drugs. 1997 Jan;53(1):40-73. doi: 10.2165/00003495-199753010-00004. Drugs. 1997. PMID: 9010648 Review.

7

Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.

Liang Y, Lin H, Dzakah EE, Tang S. Liang Y, et al. Front Immunol. 2022 Mar 30;13:844023. doi: 10.3389/fimmu.2022.844023. eCollection 2022. Front Immunol. 2022. PMID: 35432309 Free PMC article.

8

AIDS, opportunistic infections, and drug therapy.

Alexander W. Alexander W. Nurs Outlook. 1993 May-Jun;41(3):142. Nurs Outlook. 1993. PMID: 8102201 No abstract available.

9

Update on drug therapy for HIV and related infections in adults.

Montauk SL, Mandell K. Montauk SL, et al. Am Fam Physician. 1992 Dec;46(6):1772-81. Am Fam Physician. 1992. PMID: 1360766 Review.

10

Challenges in Treating Intraocular Inflammation in HIV Patients.

Testi I, Ahmed S, Shah C, Agrawal R. Testi I, et al. Ocul Immunol Inflamm. 2020 Oct 2;28(7):1094-1098. doi: 10.1080/09273948.2020.1726971. Epub 2020 Mar 11. Ocul Immunol Inflamm. 2020. PMID: 32159416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,522 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61,522 results

Results by year